Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI.
Saved in:
| Title: | Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI. |
|---|---|
| Authors: | Simic P; Division of Nephrology and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. psimic@partners.org., Vela Parada XF; Division of Nephrology and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Parikh SM; Division of Nephrology and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Dellinger R; Elysium Health Inc., New York, NY, USA., Guarente LP; Elysium Health Inc., New York, NY, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Rhee EP; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute, Cambridge, MA, USA. |
| Source: | BMC nephrology [BMC Nephrol] 2020 Aug 13; Vol. 21 (1), pp. 342. Date of Electronic Publication: 2020 Aug 13. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
